Instead, OPG expression from CRC cells suppresses M2 macrophage activity by inhibiting NFκB, PI3K, and MAPK signaling pathways, the major RANKL-RANK pathways (Fig. 3A,B). The gene discussed is TNFRSF11A; the disease is colorectal carcinoma.